Please assess the completion status of the following clinical trial:

Trial Title: A Study of Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* adult patients, \>=18 years of age;~* documented inoperable, locally advanced, metastatic or recurrent non-squamous NSCLC;~* adequate liver and kidney function;~* women of childbearing potential must have a negative serum pregnancy test within 7 days of starting study treatment.~Exclusion Criteria:~* prior chemotherapy or treatment with another systemic cancer therapy;~* surgery (including open biopsy), significant traumatic injury, or radiotherapy within the last 4 weeks prior to first dose of study treatment;~* brain metastasis or spinal cord compression;~* fertile men, and women of childbearing potential, not using adequate contraception;~* treatment with any other investigational agent, or participation in another clinical trial, within 30 days prior to entering the study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None
- 2 (Type: EXPERIMENTAL): None
- 3 (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).